Clinical Trial Update: IDO2 Genetic Status Informs the Neoadjuvant Efficacy of Chloroquine (CQ) in Brain Metastasis Radiotherapy [NA]

View source ↗

Summary

This document reports a completed clinical trial evaluating whether IDO2 genetic status influences the neoadjuvant efficacy of chloroquine during brain metastas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases

Drugs mentioned

• Chloroquine (chloroquine)

Snippet

Sponsor: Main Line Health | Conditions: Brain Metastasis | NA | Status: COMPLETED